Canada markets close in 5 hours 46 minutes

Comera Life Sciences Holdings, Inc. (CMRA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.03000.0000 (0.00%)
As of 01:39PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 922.13k
Enterprise Value -674.14k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.59
Price/Book (mrq)N/A
Enterprise Value/Revenue -0.67
Enterprise Value/EBITDA 0.08

Trading Information

Stock Price History

Beta (5Y Monthly) 0.39
52-Week Change 3-95.73%
S&P500 52-Week Change 322.38%
52 Week High 30.7740
52 Week Low 30.0220
50-Day Moving Average 30.0409
200-Day Moving Average 30.2131

Share Statistics

Avg Vol (3 month) 314.39k
Avg Vol (10 day) 324.27k
Shares Outstanding 530.74M
Implied Shares Outstanding 630.74M
Float 88.54M
% Held by Insiders 170.47%
% Held by Institutions 19.93%
Shares Short (Oct 31, 2023) 4281.55k
Short Ratio (Oct 31, 2023) 40.84
Short % of Float (Oct 31, 2023) 41.36%
Short % of Shares Outstanding (Oct 31, 2023) 40.92%
Shares Short (prior month Sept 29, 2023) 427.93k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,582.47%

Management Effectiveness

Return on Assets (ttm)-119.35%
Return on Equity (ttm)-1,629.02%

Income Statement

Revenue (ttm)1M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)-42.00%
Gross Profit (ttm)N/A
EBITDA -7.55M
Net Income Avi to Common (ttm)-9.35M
Diluted EPS (ttm)-0.2200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.77M
Total Cash Per Share (mrq)0.06
Total Debt (mrq)561.47k
Total Debt/Equity (mrq)549.04%
Current Ratio (mrq)0.90
Book Value Per Share (mrq)-0.14

Cash Flow Statement

Operating Cash Flow (ttm)-6.66M
Levered Free Cash Flow (ttm)-2.99M